Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Qilu Pharmaceutical Co., Ltd..
Real, source-linked trial activity for Qilu Pharmaceutical Co., Ltd.: 3 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 22, 2026. Source-linked, daily-refreshed.
PHASE1 1PHASE3 1PHASE1/PHASE2 1
Newest Qilu Pharmaceutical Co., Ltd. trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | Pharmacokinetic (PK) Study of QL1203 and Vectibix® for the Treatment o | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 19d ago | A Study Comparing QLC5508 in Combination With QL2107 Versus Tislelizum | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 55d ago | Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics | Ph 1/Ph 2 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Qilu Pharmaceutical Co., Ltd. (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.